ghk-cu mechanism of action gene modulation 89030-95-5 Gly-His-Lys-Cu Copper Tripeptide-1; Prezatide copper Copper Peptide (GHK-Cu): Clinical Uses,

BPC-157 in stroke recovery: Neuroprotection and cognitive benefits

Any reference to biological activity or potential effects is based solely on preclinical or in-vitro findings and should not be interpreted as validated clinical outcomes

Composition GHK-Cu: 50 mg BPC-157: 10 mg TB-500 (Thymosin Beta 4): 10 mg Appearance: lyophilized powder in a sealed research vial Research Focus (non-clinical) Combined evaluation of copper peptide, BPC-157, and TB-500 in in-vitro or ex-vivo assay systems Assay development, including chromatographic separation of three co-formulated peptides Stability characterization of a three-analyte lyophilized blend under laboratory storage conditions Method documentation for HPLC/LC-MS identity and purity assessments Documentation Analysis Report Important Notice For research use only Not for human consumption Not intended to diagnose, treat, cure, or prevent any disease Quality & Manufacturing Lot-specific COA Lyophilized for transit stability

How does GHK-Cu work, and what are the potential benefits

GH was measured by immunoenzymometric assay (E Test TOSOH II HGH

Trained professionals administer hangover recovery drips safely